Prof. Nava Zisapel

Co-Founder and Chairperson

Prof. Zisapel is Founder and Chief Scientific Officer of Neurim Pharmaceuticals, Ltd. She is a full professor at Tel-Aviv University with a specialization in Neuro-biochemistry and holds the Michael Gluck Chair in Neuropharmacology and ALS Research - USA. Prof. Zisapel holds a B.Sc. in Chemistry, a M.Sc. in Biochemistry and a Ph.D. in Biochemistry from Tel-Aviv University. She has authored, together with her students and other scientists, over 160 original research publications in peer-reviewed journals. 

Yehuda Zisapel


Mr. Zisapel is the Founder and President of the RAD-Bynet Group, whose unique philosophy inspired the Israeli government’s creation of its first incubator program. Mr. Zisapel has a successful three-decade track record of seed-stage investing, including the co-founding of Neurim Pharmaceuticals, Ltd., a privately held drug discovery and development company. Mr. Zisapel is a Member of the Board of Directors of numerous RAD-Bynet Group companies

Kobi Elad, Adv.

Legal Counsel

Mr. Elad serves as legal counsel for RAD BioMed as a whole and for its investee companies. 
With extensive experience in advising and supporting start-up companies, Mr. Elad consults with investee companies regarding corporate law, fundraising transactions, strategic partnerships, clinical trials, licensing, and other commercial transactions.
He holds a B.A. in Social Sciences from the Hebrew University in Jerusalem and an L.L.B. degree from Tel Aviv University and has been a member of the Israeli Bar Association since 1996.

Please reload